Narek Shaverdian, MD

About Me

  • Clinical Expertise: Lung Cancer; Brain Cancer and Other Central Nervous System Tumors; Prostate Cancer; Image-Guided Radiation Therapy (IGRT); Intensity-Modulated Radiation Therapy (IMRT); Streotactic Radiosurgery (SRS); Stereotactic Body Radiation Therapy (SBRT); Stereotactic Ablative Radiotherapy (SABR)
  • Awards and Honors: Radiological Society of North America (RSNA) Roentgen Research Award (2018); American Society for Radiation Oncology (ASTRO) Basic/Translational Science Abstract Award (2017); American Society for Clinical Oncology (ASCO) Merit Award (2017); American Medical Association (AMA) Foundation Seed Grant (2017); American College of Radiation Oncology (ACRO) Grant (2015); Alpha Omega Alpha Honor Medical Society (2013)
  • Languages Spoken: English
  • Education: MD, University of Wisconsin
  • Residencies: Preliminary Medicine - University of Washington; Radiation Oncology - University of California Los Angeles


Shaverdian N, Wang X, Hegde JV, Aledia C, Weidhaas JB, Steinberg ML, McCloskey SA. The patient’s perspective on breast radiation therapy: Initial fears and expectations versus reality. Cancer. 2018 Apr 15;124(8):1673-1681

Shaverdian N, Lisberg AE, Bornazyan K, Veruttipong D, Goldman JW, Formenti SC, Garon EB, Lee P. Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial. Lancet Oncology. 2017 Jul;18(7):895-903.

Shaverdian N, Veruttipong D, Wang PC, Kishan AU, Demanes DJ, McCloskey S, Kupelian P, Steinberg ML, King CR. Exploring value from the patient’s perspective between modern radiation therapy modalities for localized prostate cancer. International Journal of Radiation Oncology, Biology, and Physics. 2017 Mar 1;97(3):516-525.

Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

Shaverdian N, Veruttipong D, Wang J, Kupelian P, Steinberg M, Lee P. Pretreatment anemia portends poor survival and nonlocal disease progression in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy. Journal of Thoracic Oncology. 2016 Aug;11(8):1319-25.

Shaverdian N, Wang PC, Steinberg M, Lee P. The patient’s perspective on stereotactic body radiation therapy vs. surgery for the treatment of early stage non-small cell lung cancer. Lung Cancer. 2015 Nov;90(2):230-3.

Visit PubMed for a full listing of Narek Shaverdian’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more Arrow rightAn icon showing an arrow pointing to the right.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.